Understanding the control of hypercholesterolemia and dyslipidemia beginning in midlife, when its detrimental effects to brain health are thought to be most pervasive (Anstey et al., 2017), may provide new insights into the potential use of statins and or the identification of novel targets that could advance midlife preventive strategies for dementia in certain populations
Zepbound belongs to a group of drugs called dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists
Is there evidence supporting maintenance on a lower dose rather than complete discontinuation
This study has limitations, including a small number of participants and its nature as a retrospective analysis of existing medical records without a comparison group
has served as a consultant to Alexion, EMD Serono, Genentech, Genzyme, Horizon, Novartis and TG Therapeutics